# Orexigen Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orexigen-therapeutics

- Industry: Pharmaceuticals
- Headquarters: US
- Website: www.orexigen.com
- Total disclosed funding: $76M
- Latest round: Series C (Nov 22, 2006)
- Investors on record: 8

## About

Founded in 2009 and based in California, US, Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on developing medicine for the treatment of obesity.

## Funding rounds

- Series C, Nov 22, 2006, $30M — Domain Associates, Kleiner Perkins, Morgenthaler Ventures, Sofinnova Investments, Montreux Equity Partners, Scale Venture Partners, MPM BioImpact, Wasatch Global Investors
- Series B, Apr 1, 2005, $35M — Domain Associates, Kleiner Perkins, Morgenthaler Ventures, Sofinnova Investments, Montreux Equity Partners, Scale Venture Partners
- Series A, Jan 1, 2004, $11M — Domain Associates, Kleiner Perkins, Sofinnova Investments

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A, Series B, Series C
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B, Series C
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B, Series C
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series B, Series C
- Montreux Equity Partners (https://capitalatlas.ai/funds/montreux-equity-partners) — Series B, Series C
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series B, Series C
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C
- Wasatch Global Investors — Series C